» Articles » PMID: 14563970

Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke

Overview
Journal Stroke
Date 2003 Oct 18
PMID 14563970
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: We sought to characterize the spatial and temporal evolution of human cerebral infarction. Using a novel method of quantitatively mapping the distribution of hypoxic viable tissue identified by 18F-fluoromisonidazole (18F-FMISO) PET relative to the final infarct, we determined its evolution and spatial topography in human stroke.

Methods: Patients with acute middle cerebral artery territory stroke were imaged with 18F-FMISO PET (n=19; <6 hours, 4; 6 to 16 hours, 4; 16 to 24 hours, 5; 24 to 48 hours, 6). The hypoxic volume (HV) comprised voxels with significant (P<0.05; >1 mL) uptake on statistical parametric mapping compared with 15 age-matched controls. Central, peripheral, and external zones of the corresponding infarct on the anatomically coregistered delayed CT were defined according to voxel distance from the infarct center and subdivided into 24 regions by coronal, sagittal, and axial planes. Maps ("penumbragrams") displaying the percentage of HV in each region were generated for each time epoch.

Results: Higher HV was observed in the central region of the infarct in patients studied within 6 hours of onset (analysis of covariance [ANCOVA]; P<0.05) compared with those studied later, in whom the HV was mainly in the periphery or external to the infarct. HV was maximal in the superior, mesial, and posterior regions of the infarct (ANCOVA; P<0.05).

Conclusions: These observations suggest that infarct expansion occurs at the expense of hypoxic tissue from the center to the periphery of the ischemic region in humans, similar to that seen in experimental animal models. These findings have important pathophysiological and therapeutic implications.

Citing Articles

Relative improvement in language vs. motor functions with reperfusion therapies for large vessel occlusion.

Ahmed Z, Yedavalli V, Gonzalez W, Hillis A Sci Rep. 2025; 15(1):6683.

PMID: 39994323 PMC: 11850585. DOI: 10.1038/s41598-025-90871-x.


Effect of intravenous thrombolysis on core growth rate in patients with acute cerebral infarction.

Wang X, Zhang H, Wang Q, Li G, Shen H, Xiao Y Front Neurol. 2023; 14:1096605.

PMID: 36908588 PMC: 9996056. DOI: 10.3389/fneur.2023.1096605.


Optimizing Emergency Stroke Transport Strategies Using Physiological Models.

Paydarfar D, Paydarfar D, Mucha P, Chang J Stroke. 2021; 52(12):4010-4020.

PMID: 34407639 PMC: 8607917. DOI: 10.1161/STROKEAHA.120.031633.


The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [F]FMISO and [Cu]CuATSM.

Little P, Arnberg F, Jussing E, Lu L, Jensen A, Mitsios N J Cereb Blood Flow Metab. 2020; 41(3):617-629.

PMID: 32423333 PMC: 7922752. DOI: 10.1177/0271678X20923857.


Factors influencing infarct growth including collateral status assessed using computed tomography in acute stroke patients with large artery occlusion.

Jiang B, Ball R, Michel P, Li Y, Zhu G, Ding V Int J Stroke. 2019; 14(6):603-612.

PMID: 31096871 PMC: 8117172. DOI: 10.1177/1747493019851278.